Tesi Raymond Joseph - Feb 16, 2023 Form 4 Insider Report for Inmune Bio, Inc. (INMB)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Raymond Joseph Tesi
Stock symbol
INMB
Transactions as of
Feb 16, 2023
Transactions value $
$0
Form type
4
Date filed
2/21/2023, 03:09 PM
Previous filing
May 31, 2022
Next filing
Apr 23, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INMB Option (right to buy) Award $0 +160K $0.00 160K Feb 16, 2023 Common Stock 160K $9.74 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted pursuant to the 2021 Stock Incentive Plan. One third (1/3) of the Option will vest at the one-year anniversary of the grant date and the remaining unvested Option will become vested and exercisable 1/24th every month thereafter until the Option is 100% vested which shall occur on the three-year anniversary of the grant date.